| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/05/1998 | WO1998008503A1 Therapeutic methods and compositions involving isoflavones |
| 03/05/1998 | WO1998008480A2 Method of using tetracycline compounds for inhibition of nitric oxide production |
| 03/05/1998 | WO1998001554A3 Secreted proteins and polynucleotides encoding them |
| 03/05/1998 | CA2670296A1 Method of using tetracycline compounds for inhibition of nitric oxide production |
| 03/05/1998 | CA2599944A1 P-selectin ligand proteins |
| 03/05/1998 | CA2265049A1 Therapeutic methods and compositions involving isoflavones |
| 03/05/1998 | CA2264266A1 1,3-diheterocyclic metalloprotease inhibitors |
| 03/05/1998 | CA2264045A1 Heterocyclic metalloprotease inhibitors |
| 03/05/1998 | CA2264044A1 Spirocyclic metalloprotease inhibitors |
| 03/05/1998 | CA2264020A1 Inhibitors of phospholipase enzymes |
| 03/05/1998 | CA2263999A1 Integrin antagonists |
| 03/05/1998 | CA2263932A1 1,4-heterocyclic metalloprotease inhibitors |
| 03/05/1998 | CA2263928A1 Substituted cyclic amine metalloprotease inhibitors |
| 03/05/1998 | CA2263914A1 Bidentate metalloprotease inhibitors |
| 03/05/1998 | CA2263817A1 Therapeutic combinations of rar antagonists and rxr agonists and use thereof |
| 03/04/1998 | EP0826685A1 Stable, long acting salts of carboxamides for the treatment of joint disease |
| 03/04/1998 | EP0826676A1 Oxazole derivatives and use thereof |
| 03/04/1998 | EP0826657A1 Compounds for modulation of hormone receptors, compositions containing them and their use in therapy |
| 03/04/1998 | EP0826368A1 Use of retinoids for the preparation of a medicament for treating disorders related to VEGF overexpression |
| 03/04/1998 | EP0826000A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses |
| 03/04/1998 | EP0825993A1 Xanthines and their therapeutic use |
| 03/04/1998 | EP0825991A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists |
| 03/04/1998 | EP0825989A1 Substituted oxazoles for the treatment of inflammation |
| 03/04/1998 | EP0825984A1 Novel method |
| 03/04/1998 | EP0825981A1 Novel heterocyclic compounds |
| 03/04/1998 | EP0825856A1 Irritation relief using nonsteroidal anti-inflammatory compounds |
| 03/04/1998 | CN1175246A Substituted azetidin-2-ones for treatment of atherosclerosis |
| 03/04/1998 | CN1175213A Irrigation solution and method for inhibition of pain, inflammation |
| 03/04/1998 | CN1175210A 4,4-(disubstituted) cyclohexan-1-ols and related compounds |
| 03/04/1998 | CN1175209A 3, 3 -(disubstituted) cyclohexan -1 -ols monomers and related compounds |
| 03/04/1998 | CN1174836A Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 03/04/1998 | CN1174725A Process for brewing Wujie wine |
| 03/03/1998 | US5723681 3,3-(disubstituted)cyclohexan-1-01 dimers and related compounds |
| 03/03/1998 | US5723583 Antibody containing sialyl lewis X determinants |
| 03/03/1998 | US5723575 Process for the preparation of backbone cyclic peptides |
| 03/03/1998 | US5723499 Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 03/03/1998 | US5723492 LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use |
| 03/03/1998 | US5723485 Analgesic, antiinflammatory agents |
| 03/03/1998 | US5723480 Adhesion receptor antagonists III |
| 03/03/1998 | US5723465 Inhibitors for cell adhesion and cellular infiltration |
| 03/03/1998 | US5723460 Potent and selective phosphodiesterase type iv inhibitors; useful in the prophylaxis and treatment of disease such as asthma where unwanted inflammatory response or muscular spasm is present |
| 03/03/1998 | US5723444 Enzyme inhibitors and anticoagulants |
| 03/03/1998 | US5723316 α-1-antichymotrypsin analogues having chymase inhibiting activity |
| 03/03/1998 | US5723120 Method of treating an IL-6 related disease with interleukin-6 receptor antagonists |
| 03/02/1998 | CA2213690A1 Use of retinoid in preparing a medication to treat disorders related to overexpression of vegf |
| 02/26/1998 | WO1998007855A2 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | WO1998007715A1 Novel benzofuran-4-carboxamides |
| 02/26/1998 | WO1998007714A1 5-substituted and 5,5-disubstituted-3,4-dihydroxy-2(5h)-furanones and methods of use therefor |
| 02/26/1998 | WO1998007701A1 Non-ulcerogenic analgesic/anti-inflammatory clonixin derivative |
| 02/26/1998 | WO1998007694A1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 02/26/1998 | WO1998007436A1 Treatment of autoimmune diseases |
| 02/26/1998 | WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/26/1998 | WO1997039123A3 Secreted proteins |
| 02/26/1998 | WO1997038966A3 Cytoprotective compounds |
| 02/26/1998 | CA2264064A1 Imidazole compounds, compositions and use |
| 02/26/1998 | CA2264000A1 5-substituted and 5,5-disubstituted-3,4-dihydroxy-2(5h)-furanones and methods of use therefor |
| 02/26/1998 | CA2263192A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | CA2262788A1 Non-ulcerogenic analgesic/anti-inflammatory clonixin derivative |
| 02/25/1998 | EP0824916A1 Pranoprofen eyedrops containing organic amine |
| 02/25/1998 | EP0824910A2 Use of a Krill Enzyme for the Treatment of Dental Plaque |
| 02/25/1998 | EP0824588A1 Il-6 activity inhibitor |
| 02/25/1998 | EP0824583A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
| 02/25/1998 | EP0824546A2 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/25/1998 | EP0824544A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use |
| 02/25/1998 | EP0824543A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use |
| 02/25/1998 | EP0824538A1 Saccharopeptides and derivatives thereof |
| 02/25/1998 | EP0824530A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 02/25/1998 | EP0713490B1 C-22 ring stabilized rapamycin derivatives |
| 02/25/1998 | EP0581916B1 Anti-proliferative and anti-inflammatory compounds: 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom |
| 02/25/1998 | CN1174554A Rapamycin 42-oximes and hydroxylamines |
| 02/25/1998 | CN1174192A New benzimidazole, benzoxazole and benzothiazole compounds, process for preparing them and pharmaceutical compositions containing them |
| 02/25/1998 | CN1174061A Chinese medicine capsule for rheumatoid disease |
| 02/25/1998 | CN1037511C Prep. of 1 -( aralkyl amino-alkyl) imidazole compounds |
| 02/24/1998 | US5721356 Orally active adenosine kinase inhibitors |
| 02/24/1998 | US5721351 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/24/1998 | US5721260 Heterocyclic compounds |
| 02/24/1998 | US5721255 Useful for preventing pain, anxiety, migrane, schizophrenia, asthma, rheumatoid arthritis, fibrositis, or ulcerative colitis in mammal |
| 02/24/1998 | US5721254 Antiinflammatory agents; analgesics |
| 02/24/1998 | US5721238 2,8-disubstituted quinazolinones |
| 02/24/1998 | US5721237 Administering for the selective treatment of cell growth and differentiation |
| 02/24/1998 | US5721222 Inhibitors of human leukocyte elastase |
| 02/24/1998 | US5720974 Compression molding mixture of active material, carbohydrate and water |
| 02/24/1998 | CA2154103C Treatment of mucous membrane disease, trauma or condition and for the relief of pain |
| 02/21/1998 | CA2213361A1 Stable, long acting salts of carboxamides for the treatment of joint disease |
| 02/19/1998 | WO1998006844A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12) |
| 02/19/1998 | WO1998006741A1 Thrombin inhibitors |
| 02/19/1998 | WO1998006740A1 Dipeptide benzamidine as a kininogenase inhibitor |
| 02/19/1998 | WO1998006733A1 Nucleotide sequence encoding the cd33-like protein |
| 02/19/1998 | WO1998006730A1 Modified oligosaccharides |
| 02/19/1998 | WO1998006715A1 Novel piperazine containing compounds |
| 02/19/1998 | WO1998006708A1 Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide |
| 02/19/1998 | WO1998006704A1 Arylalkanoyl pyridazines |
| 02/19/1998 | WO1998006703A1 2-phenyl benzimidazole derivatives as mcp-1 antagonists |
| 02/19/1998 | WO1998006692A1 Novel immunotherapeutic agents and their use in the reduction of cytokine levels |
| 02/19/1998 | WO1998006437A2 Compositions and methods for polynucleotide delivery |
| 02/19/1998 | WO1998006425A1 Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin |
| 02/19/1998 | WO1998006399A1 Il-8 receptor antagonists |
| 02/19/1998 | WO1998006387A2 Oral composition comprising 5-aminosalicylic acid |
| 02/19/1998 | WO1998006248A2 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH α4β7 INTEGRIN |
| 02/19/1998 | WO1997048799A3 Polynucleotides from human fetal brain encoding secreted proteins |